Iovance Biotherapeutics, Inc. (IOVA)
3.82
+0.18
(+4.95%)
USD |
NASDAQ |
Apr 15, 16:00
3.85
+0.03
(+0.79%)
After-Hours: 20:00
Iovance Biotherapeutics Research and Development Expense (Annual) : 300.27M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Orthofix Medical, Inc. | 65.85M |
| InfuSystem Holdings, Inc. | -- |
| Axogen, Inc. | 32.88M |
| KalVista Pharmaceuticals, Inc. | 55.64M |
| Lantheus Holdings, Inc. | 177.31M |